AXSM
NASDAQ · Pharmaceuticals
Axsome Therapeutics Inc
$247.85
-2.65 (-1.06%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+63.01%
1Y
+143.83%
YTD
+38.70%
Open$249.05
Previous Close$250.50
Day High$253.00
Day Low$245.94
52W High$260.19
52W Low$96.09
Volume—
Avg Volume715.9K
Market Cap12.89B
P/E Ratio—
EPS$-3.74
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$171.07
Above
SMA 200
$131.37
Above
RSI (14)
51.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-73.4% upside
Current
$247.85
$247.85
Target
$66.03
$66.03
$47.60
$66.03 avg
$88.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 660.48M | 1.74B | 1.62B |
| Net Income | -189,480,013 | 523.27M | 458.37M |
| Profit Margin | -28.7% | 30.1% | 28.3% |
| EBITDA | -176,651,093 | 948.73M | 868.54M |
| Free Cash Flow | — | 423.20M | 592.85M |
| Rev Growth | +133.7% | -6.3% | -6.3% |
| Debt/Equity | 3.25 | 0.60 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |